SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-251322
Filing Date
2017-08-08
Accepted
2017-08-08 16:07:48
Documents
53
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d408983d10q.htm 10-Q 613655
2 EX-31.1 d408983dex311.htm EX-31.1 6633
3 EX-31.2 d408983dex312.htm EX-31.2 6652
4 EX-32.1 d408983dex321.htm EX-32.1 4014
5 EX-32.2 d408983dex322.htm EX-32.2 4033
  Complete submission text file 0001193125-17-251322.txt   2877139

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kpti-20170630.xml EX-101.INS 446112
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20170630.xsd EX-101.SCH 34556
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20170630_cal.xml EX-101.CAL 49611
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20170630_def.xml EX-101.DEF 117436
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20170630_lab.xml EX-101.LAB 309009
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20170630_pre.xml EX-101.PRE 205988
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 171014768
SIC: 2834 Pharmaceutical Preparations